Pharmacokinetics of phenobarbital following single and repeated doses

Journal of Clinical Pharmacology
C T ViswanathanP G Welling

Abstract

Serum levels of phenobarbital, and also urinary excretion of phenobarbital and p-hydroxyphenobarbital, were examined after single and repeated oral doses of phenobarbital to three male subjects. Serum levels of phenobarbital at steady state were approximately ten times as high as those after a single dose. The overall elimination rate constant for loss of phenobarbital from serum, Kel, was significantly reduced after repeated doses, and Cmax infinity values calculated from single-dose data poorly predicted observed Cmax infinity values. Five-day urinary excretion of phenobarbital and p-hydroxyphenobarbital accounted for 16 and 21 per cent, respectively, of the initial dose. Due to extensive drug accumulation, 83 per cent of the final dose was excreted in five-day urine as phenobarbital and 85 per cent, as p-hydroxyphenobarbital. Comparison of plasma and renal clearances indicated that the rate of phenobarbital metabolism was reduced owing to repeated dosing, while the rate of urinary excretion of parent drug was unchanged.

References

Mar 1, 1977·Clinical Pharmacokinetics·D D Breimer
Feb 1, 1978·Journal of Clinical Pharmacology·C T ViswanathanP G Welling
Dec 1, 1972·Proceedings of the Society for Experimental Biology and Medicine·E Jähnchen, G Levy
Mar 1, 1967·Toxicology and Applied Pharmacology·R M WelchJ J Burns
Feb 16, 1970·FEBS Letters·S OrreniusL Ernster

Citations

Jan 1, 1980·European Journal of Clinical Pharmacology·P J Neuvonen, E Elonen
Sep 9, 1982·The New England Journal of Medicine·M J BergG F Johnson
Apr 5, 2013·Expert Opinion on Drug Metabolism & Toxicology·Graham LappinTal Burt
May 5, 2011·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Graham LappinColin Garner
Jul 17, 2007·Journal of the Neurological Sciences·Marek A Mirski, Mitzi K Hemstreet
Jan 1, 1985·Journal of Clinical Pharmacology·T R BrowneD J Greenblatt
Mar 14, 2017·Journal of Pain & Palliative Care Pharmacotherapy·John Bodnar
Nov 1, 1987·Drug Intelligence & Clinical Pharmacy·J W GingeryJ A Jernigan
Apr 29, 2019·Clinical Pharmacokinetics·Merel van NulandJos H Beijnen
Nov 1, 1984·Drug Intelligence & Clinical Pharmacy·E SaltielW I Young

Related Concepts

Half-Life
Hydroxylation
Luminal

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Synthetic Genetic Array Analysis

Synthetic genetic arrays allow the systematic examination of genetic interactions. Here is the latest research focusing on synthetic genetic arrays and their analyses.

Congenital Hyperinsulinism

Congenital hyperinsulinism is caused by genetic mutations resulting in excess insulin secretion from beta cells of the pancreas. Here is the latest research.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Epigenetic Memory

Epigenetic memory refers to the heritable genetic changes that are not explained by the DNA sequence. Find the latest research on epigenetic memory here.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Femoral Neoplasms

Femoral Neoplasms are bone tumors that arise in the femur. Discover the latest research on femoral neoplasms here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.